Amid the controversy, the Serum Institute, a vaccine manufacturer in India, has clarified. They claim that the production and supply of Covishield in the Indian market has been stopped since December 2021. The company has issued a notification stating that the production of the vaccine has been stopped since December 2021. There is currently no demand for this vaccine in the country.” It has also been informed that, “The company has informed about rare side effects such as thrombosis, thrombocytopenia syndrome inside the packaging. We have maintained transparency.” A few days ago, in the context of a court case, AstraZeneca admitted that there is a risk of side effects if you take the Covishield vaccine. It creates the possibility of thrombosis or thrombocytopenia syndrome in vaccine recipients. Panic arose after this admission. After that, there was an uproar over AstraZeneca’s announcement to stop Covishield.
Covishield vaccine suspended in the country for 2 years, Serum issues statement amid controversy
